Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: a randomised dose-ranging study

✍ Scribed by Follows, Richard MA ;Snowise, Neil G ;Ho, Shu-Yen ;Ambery, Claire L ;Smart, Kevin ;McQuade, Barbara A

• Book ID: 120685144
• Publisher: BMJ
• Year: 2013
• Tongue: English
• Weight: 364 KB
• Volume: 14
• Category: Article
• ISSN: 2052-4439
• DOI: 10.1186/1465-9921-14-54